Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Special Issue: Current evidence and perspectives for hypertension management in Asia
  • Published:

Sex-specific associations between serum uric acid levels and risk of hypertension for different diagnostic reference values of high blood pressure

Hypertension Research volume 47, pages 1120–1132 (2024)Cite this article

Abstract

The association between uric acid (UA) and hyperuricemia with 5-year hypertension incidence using different blood pressure (BP) diagnostic references in men and women without cardiometabolic diseases is unknown. We used the checkup data from Kagoshima Kouseiren Hospital. All participants with hypertension or on BP medication, diabetes, dyslipidemia, obesity, estimated glomerular filtration rate<60 ml/min/1.73m2, metabolic syndrome, history of gout, and UA-lowering medication were excluded. UA was categorized into sex-specific quartiles and hyperuricemia was defined as UA > 7 mg/dl in men and UA > 6 mg/dl in women. We performed multivariate logistic regression to assess the effects of UA on hypertension development. The 5-year hypertension incidence was defined as subsets of BP ≥ 140/90 mmHg in cohort 1 and BP ≥ 130/80 mmHg in cohort 2. The study enrolled 21,443 participants (39.8%, men) in cohort 1 and 15,245 participants (36.5%, men) in cohort 2. The incidence of hypertension in cohorts 1 and 2 over 5 years was 16.3% and 29.7% in men and 10.9% and 21.4% in women, respectively. When comparing the fourth to the first UA quartile, there was an association with hypertension in men in cohort 1, with odds ratio (OR): 1.36 (95% confidence interval [CI], 1.13–1.63, p < 0.01) and cohort 2, OR: 1.31 (95%CI, 1.09–1.57, p < 0.01), respectively, but not in women. Additionally, an association between hyperuricemia and hypertension was observed in men only in cohort 1, with OR: 1.23 (95%CI, 1.07–1.42, p = 0.02), and in women in cohort 2, OR: 1.57 (95%CI, 1.14–2.16, p < 0.01). The effect of UA on the development of hypertension is influenced by sex and incidence differs with the BP reference used.

Uric acid effect on the development of hypertension is affected by sex and incidence differs with the BP reference used.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.

    Article  PubMed  PubMed Central  Google Scholar 

  3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389:37–55.

    Article  Google Scholar 

  4. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:1269–324.

    Article  CAS  PubMed  Google Scholar 

  5. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice guidelines. Hypertension. 2020;75:1334–57.

    Article  CAS  PubMed  Google Scholar 

  6. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023;41:1874–2071.

    Article  CAS  PubMed  Google Scholar 

  7. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

    Article  PubMed  Google Scholar 

  8. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hisatome I, Li P, Miake J, Taufiq F, Mahati E, Maharani N, et al. Uric acid as a risk factor for chronic kidney disease and cardiovascular disease—Japanese guideline on the management of asymptomatic hyperuricemia. Circ J. 2021;85:130–8.

    Article  CAS  PubMed  Google Scholar 

  10. Yu W, Cheng JD. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharm. 2020;11:582680.

    Article  CAS  Google Scholar 

  11. Lanaspa MA, Andres-Hernando A, Kuwabara M. Uric acid and hypertension. Hypertens Res. 2020;43:832–4.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez CA, Andres-Hernando A, et al. Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: 5-year Japanese cohort study. Hypertension. 2017;69:1036–44.

    Article  CAS  PubMed  Google Scholar 

  13. Stewart DJ, Langlois V, Noone D. Hyperuricemia and Hypertension: Links and Risks. Integr Blood Press Control. 2019;12:43–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25:39–42.

    Article  CAS  PubMed  Google Scholar 

  15. Qu LH, Jiang H, Chen JH. Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis. Ann Med. 2017;49:142–56.

    Article  CAS  PubMed  Google Scholar 

  16. Gunawardhana L, McLean L, Punzi HA, Hunt B, Palmer RN, Whelton A, et al. Effect of febuxostat on ambulatory blood pressure in subjects with hyperuricemia and hypertension: a phase 2 randomized placebo‐controlled study. J Am Heart Assoc. 2017;6:e006683.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008;300:924.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Engel B, Hoffmann F, Freitag MH, Jacobs H. Should we be more aware of gender aspects in hyperuricemia? Analysis of the population-based German health interview and examination survey for adults (DEGS1). Maturitas. 2021;153:33–40.

    Article  PubMed  Google Scholar 

  19. Kuwabara M, Hisatome I, Niwa K, Bjornstad P, Roncal-Jimenez CA, Andres-Hernando A, et al. The optimal range of serum uric acid for cardiometabolic diseases: a 5-year Japanese cohort study. J Clin Med. 2020;9:942.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Cheng F, Li Y, Zheng H, Tian L, Jia H. Mediating effect of body mass index and dyslipidemia on the relation of uric acid and type 2 diabetes: results from China health and retirement longitudinal study. Front Public Health. 2021;9:823739.

    Article  PubMed  Google Scholar 

  21. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 2012;220:525–31.

    Article  CAS  PubMed  Google Scholar 

  22. Sumiyoshi H, Ohyama Y, Imai K, Kurabayashi M, Saito Y, Nakamura T. Association of uric acid with incident metabolic syndrome in a Japanese general population. Int Heart J. 2019;60:830–5.

    Article  CAS  PubMed  Google Scholar 

  23. Kawasoe S, Kubozono T, Yoshifuku S, Ojima S, Miyata M, Miyahara H, et al. Uric acid level and new-onset atrial fibrillation in the Japanese General population- longitudinal study. Circ J. 2018;83:156–63.

    Article  PubMed  Google Scholar 

  24. Nyrnes A, Toft I, Njølstad I, Mathiesen EB, Wilsgaard T, Hansen JB, et al. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women-the Tromso Study. Europace. 2014;16:320–6.

    Article  PubMed  Google Scholar 

  25. Shani M, Vinker S, Dinour D, Leiba M, Twig G, Holtzman EJ, et al. High normal uric acid levels are associated with an increased risk of diabetes in lean, normoglycemic healthy women. J Clin Endocrinol Metab. 2016;101:3772–8.

    Article  CAS  PubMed  Google Scholar 

  26. Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, et al. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res. 2012;35:1087–92.

    Article  CAS  PubMed  Google Scholar 

  27. Kikuchi A, Kawamoto R, Ninomiya D, Kumagi T. Hyperuricemia is associated with all-cause mortality among males and females: findings from a study on Japanese community-dwelling individuals. Metab Open. 2022;14:100186.

    Article  CAS  Google Scholar 

  28. Antón FM, García Puig J, Ramos T, González P, Ordás J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986;35:343–8.

    Article  PubMed  Google Scholar 

  29. Guan S, Tang Z, Fang X, Wu X, Liu H, Wang C, et al. Prevalence of hyperuricemia among Beijing post-menopausal women in 10 years. Arch Gerontol Geriatr. 2016;64:162–6.

    Article  CAS  PubMed  Google Scholar 

  30. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:102–10.

    Article  CAS  Google Scholar 

  31. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y, et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res. 2004;27:835–41.

    Article  PubMed  Google Scholar 

  32. Nishio S, Maruyama Y, Sugano N, Hosoya T, Yokoo T, Kuriyama S. Gender interaction of uric acid in the development of hypertension. Clin Exp Hypertens. 2018;40:446–51.

    Article  CAS  PubMed  Google Scholar 

  33. Kim W, Go TH, Kang DO, Lee J, Choi JY, Roh SY, et al. Age and sex-dependent association of uric acid and incident hypertension. Nutr Metab Cardiovasc Dis. 2021;31:1200–8.

    Article  CAS  PubMed  Google Scholar 

  34. Wang SF, Shu L, Wang S, Wang XQ, Mu M, Hu CQ, et al. Gender difference in the association of hyperuricemia with hypertension in a middle-aged Chinese population. Blood Press. 2014;23:339–44.

    Article  CAS  PubMed  Google Scholar 

  35. Mori K, Furuhashi M, Tanaka M, Higashiura Y, Koyama M, Hanawa N, et al. Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: linear mixed-effects model analyses. Hypertens Res. 2022;45:344–53.

    Article  CAS  PubMed  Google Scholar 

  36. Lin X, Wang X, Li X, Song L, Meng Z, Yang Q, et al. Gender- and age-specific differences in the association of hyperuricemia and hypertension: a cross-sectional study. Int J Endocrinol. 2019;2019:7545137.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al. Metabolic syndrome. J Atheroscler Thromb. 2008;15:1–5.

    Article  PubMed  Google Scholar 

  38. World Health Organization: Waist circumference and waist-hip ratio: report of a WHO expert consultation [Internet]. WHO Press, Geneva, Switzerland, 2011; 2008. Available from: https://www.who.int/publications/i/item/9789241501491.

  39. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  PubMed  Google Scholar 

  40. Risk NCD. Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021;398:957–80.

    Article  Google Scholar 

  41. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bundy JD, Mills KT, He J. Comparison of the 2017 ACC/AHA hypertension guideline with earlier guidelines on estimated reductions in cardiovascular disease. Curr Hypertens Rep. 2019;21:76.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Wilson PWF, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867–72.

    Article  PubMed  Google Scholar 

  44. Aronow WS. Association of obesity with hypertension. Ann Transl Med. 2017;5:350.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Salim AA, Kawasoe S, Kubozono T, Ojima S, Kawabata T, Ikeda Y, et al. Assessment of future hypertension risk by sex using combined body mass index and waist-to-height ratio. Circ Rep. 2022;4:9–16.

    Article  PubMed  Google Scholar 

  46. Rahman MA, Halder HR, Yadav UN, Mistry SK. Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh. Sci Rep. 2021;11:15420.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Liu C-W, Ke S-R, Tseng G-S, Wu Y-W, Hwang J-J. Elevated serum uric acid is associated with incident hypertension in the health according to various contemporary blood pressure guidelines. Nutr, Metab Cardiovasc Dis. 2021;31:1209–18.

    Article  CAS  PubMed  Google Scholar 

  48. Wang J, Qin T, Chen J, Li Y, Wang L, Huang H, et al. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One. 2014;9:e114259.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. 2022;79:1927–36.

    Article  CAS  PubMed  Google Scholar 

  50. Yokokawa H, Fukuda H, Suzuki A, Fujibayashi K, Naito T, Uehara Y, et al. Association between serum uric acid levels/hyperuricemia and hypertension among 85,286 Japanese workers. J Clin Hypertens. 2016;18:53–59.

    Article  CAS  Google Scholar 

  51. Nagahama K, Inoue T, Kohagura K, Kinjo K, Ohya Y. Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens Res. 2015;38:213–8.

    Article  CAS  PubMed  Google Scholar 

  52. Ohyama Y, Imai K, Obokata M, Araki M, Sumiyoshi H, Koitabashi N, et al. Impact of uric acid on incident hypertension: sex-specific analysis in different age groups. Int J Cardiol Hypertens. 2019;2:100009.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Hoshide S, Yamamoto K, Katsurada K, Yano Y, Nishiyama A, Wang JG, et al. Agreement regarding overcoming hypertension in the Asian hypertension society network 2022. Hypertens Res. 2023;46:3–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the medical staff at Kagoshima Kouseiren Hospital for their support with data collection.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

    Anwar Ahmed Salim, Shin Kawasoe, Takuro Kubozono, Satoko Ojima, Takeko Kawabata, Yoshiyuki Ikeda & Mitsuru Ohishi

  2. Kagoshima Kouseiren Hospital, Kagoshima, Japan

    Hironori Miyahara & Koichi Tokushige

Authors
  1. Anwar Ahmed Salim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shin Kawasoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takuro Kubozono
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoko Ojima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takeko Kawabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshiyuki Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hironori Miyahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Koichi Tokushige
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mitsuru Ohishi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors made substantial contribution to this work.

Corresponding author

Correspondence to Takuro Kubozono.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salim, A.A., Kawasoe, S., Kubozono, T. et al. Sex-specific associations between serum uric acid levels and risk of hypertension for different diagnostic reference values of high blood pressure. Hypertens Res 47, 1120–1132 (2024). https://doi.org/10.1038/s41440-023-01535-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01535-0

Keywords

Search

Advanced search

Quick links